While DOH has yet to issue updated guidance, the CDC has updated guidance that DOH points to in its Feb. 10^th DAL.

Issued in response to changes in the FDA's emergency use authorizations, the FAQs reiterate requirements to conduct two tests, 48 hours apart, when using antigen point-of-care or at-home tests on symptomatic individuals who test negative.

State directs providers to mask consistent with CDC guidance after Feb. 13^th.

Members can submit questions and issues to be addressed.

Guidance updates recommendations on isolation duration and exposure precautions consistent with the CDC.